Adaptive Biotechnologies (ADPT) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $25.49 +3.79%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.25), $0.11 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $71.55 million versus the consensus estimate of $65.75 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
